comparemela.com

Latest Breaking News On - Paul thielking - Page 5 : comparemela.com

Numinus Wellness Inc. Reports Q4 2022 and Annual Results

/PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and.

Germany
Arizona
United-states
Australia
Salt-lake-city
Utah
Netherlands
United-kingdom
Vancouver
British-columbia
Canada
Montreal

Numinus Launches Psychedelic-Assisted Therapy for Chronic and Serious Medical Illness

/PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and.

Salt-lake-city
Utah
United-states
United-kingdom
Quebec
Canada
Vancouver
British-columbia
British
Instagram
Numinus-wellness-inc

Numinus Wellness Inc launches Ketamine for Chronic and Serious Medical Illness Program

Numinus Wellness Inc. (TSX:NUMI, OTC:LKYSF) has announced the launch of its Ketamine for Chronic and Serious Medical Illness Program which will be.

Salt-lake-city
Utah
United-states
United-kingdom
Quebec
Canada
British
Neil-barclay
Paul-thielking
Numinus-wellness-inc
Protocol-development-at-numinus
Serious-medical-illness-program

Numinus Wellness Inc develops psilocybin-infused tea bag for use in psychedelic research

Numinus Wellness Inc. (TSX:NUMI, OTC:LKYSF) announced that it has developed a tea bag containing psilocybin for use in clinical research and, if the.

Canada
Sharan-sidhu
Paul-thielking
Cedar-clinical-research
Numinus-wellness-inc
Health-canada
Access-program
Numinus-wellness
Cedar-clinical
Special-access-program

Numinus Develops Mushroom Tea for Use in Psychedelic Research

/PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and.

Canada
Vancouver
British-columbia
Numinus-bioscience
Sharan-sidhu
Paul-thielking
Instagram
Scientific-research
Cedar-clinical-research
Numinus-wellness-inc
Linkedin
Twitter

vimarsana © 2020. All Rights Reserved.